Interní Med. 2012; 14(11): 412-414

Metabolic syndrome, its prediction and prevention

MUDr.©árka Svobodová, Ph.D.0,2, prof.MUDr.Ondřej Topolčan, CSc.
1 III. interní klinika VFN Praha a 1. LF UK Praha
2 Imunoanalytická laboratoř FN Plzeň a LF Plzeň, UK Praha

Metabolic syndrome has been associated with significantly higher risks for accelerated atherosclerosis, Type 2 diabetes mellitus, cardiovascular

and cancer diseases. These risks can be detected using individual parameters of metabolic syndrome. For primary prevention

risk should not be estimated based only on the traditional risk factors (age, sex, systolic blood pressure, total cholesterol serum level

and smoking), but also using new metabolic biomarkers. New trends of personalized medicine are currently based only on the clinical

factors. Neither risk genes detection nor metabolic factors assessment has been currently used.

Keywords: metabolic syndrome, prediction, prevention, cardiovascular risk, biomerkers

Published: December 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Svobodová ©, Topolčan O. Metabolic syndrome, its prediction and prevention. Interní Med. 2012;14(11):412-414.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kylin E. Studien über das Hypertonie-Hyperglykaemie-Hyperurika miesyndrom. Zentralblatt fuer Innere Medizin 1923; 44: 105-127.
    2. Vague J. Sexual Differentiation. A Factor affecrting the forms of Obesity. Presse Med 1947; 30: 339-340.
    3. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988; 37: 1595-1607. Go to original source... Go to PubMed...
    4. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989 Jul; 149(7): 1514-1520. Go to original source...
    5. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation 1999.
    6. Alberti KGMM, et al. Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645. Go to original source... Go to PubMed...
    7. Rankinen T, et al. The human obesity gene map. The 2005 update. Obesity 2006; 14: 529-644. Go to original source... Go to PubMed...
    8. Ford ES et al. Prevalence of metabolic syndrome among US adults: Finding from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359. Go to original source... Go to PubMed...
    9. Erem C, Hacihasanoglu A, Deger O, Topbas M, Hosver I, Ersoz HO, et al. Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study. Endocrine. Feb 2008; 33(1): 9-20. Go to original source... Go to PubMed...
    10. Kolovou GD, Anagnostopoulou KK, Salpea KD, et al. The prevalence of metabolic syndrome in various populations. Am J Med Sci. Jun 2007; 333(6): 362-371. Go to original source... Go to PubMed...
    11. Malik M, Razig SA. The prevalence of the metabolic syndrome among the multiethnic population of the United Arab Emirates: a report of a national survey. Metab Syndr Relat Disord. Fall 2008; 6(3): 177-186. Go to original source... Go to PubMed...
    12. Mokan M, Galajda P, Pridavkova D, et al. Prevalence of diabetes mellitus and metabolic syndrome in Slovakia. Diabetes Res Clin Pract. Aug 2008; 81(2): 238-242. Go to original source... Go to PubMed...
    13. Neel JV. Diabewtes mellitus a drifty genotype rendered detrimental by, ,progress"?. Am J Hum Genet 1962; 14: 353-362.
    14. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003-2006. JAMA. 2008; 299: 2401-2405. Go to original source... Go to PubMed...
    15. Abdullah AR, Hasan HA, Raigangar VL. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females. Metab Syndr Relat Disord. 2009 Feb; 7(1): 17-22. PubMed PMID: 19025443. Go to original source... Go to PubMed...
    16. Kawada T. Relationship between Several Markers and Presence of Metabolic Syndrome or Components of the Metabolic Syndrome in Japanese Workers. J Occup Environ Med. 2012 Jul 6. [Epub ahead of print] PubMed PMID: 22544164. Go to original source... Go to PubMed...
    17. Nickisch S, Kratzsch J, Gebauer C, Waldeyer T, Stepan H, Kiess W.: Glucose tolerance in women 24 h postpartum is related to blood pressure, anthropometric data, and adipokine serum levels. Hypertens Pregnancy. 2012; 31(2): 228-239. Epub 2012 Mar 1. Go to original source... Go to PubMed...
    18. Srinivasa Nageswara Rao G, Prema G, Priya G, Arumugam SB, Kirthivasan V, Saibabu R, Cherian KM. Comparison between serum insulin levels and its resistance with biochemical, clinical and anthropometric parameters in South Indian children and adolescents. Indian J Clin Biochem. 2011 Jan; 26(1): 22-27. Epub 2010 Aug 25. Go to original source... Go to PubMed...
    19. Gaillard TR, Schuster D, Osei K. Characterization of metabolically unhealthy overweight/obese African American women: significance of insulin-sensitive and insulin-resistant phenotypes. J Natl Med Assoc. 2012 Mar-Apr; 104(3-4): 164-171. Go to original source... Go to PubMed...
    20. Iudochkin AV, Sharafetdinov KhKh, Plotnikova OA, Alekseeva RI, Sentsova TB, Vorozhko IV. Features of hormone metabolism in reproductive age women with metabolit syndrome. Vopr Pitan. 2012; 81(1): 75-79. Go to PubMed...
    21. Haban P, Simoncic R, Zidekova E, Ozdin L. Role of fasting serum C-peptide as a predictor of cardiovascular risk associated with the metabolic X-syndrome. Med Sci Monit. 2002 Mar; 8(3): CR175-9.
    22. Chen CH, Tsai ST, Chou P. Correlation of fasting serum C-peptide and insulin with markers of metabolic syndrome-X in a homogenous Chinese population with normal glucose tolerance. Int J Cardiol. 1999 Feb 28; 68(2): 179-86. Go to original source... Go to PubMed...
    23. Maciejewska-Jeske M, Szczesna A, Męczekalski B. Serum C-peptide concentration in overweight and obese women with polycystic ovary syndrome. Pol Merkur Lekarski. 2010 Aug; 29(170): 93-99. Go to PubMed...
    24. Kazakou P, Kyriazopoulou V, Michalaki M, Ierodiakonou V, Psyrogiannis A, Habeos I. Activated Hypothalamic Pituitary Adrenal Axis in Patients with Metabolic Syndrome. Horm Metab Res. 2012 Apr 27. [Epub ahead of print] Go to original source... Go to PubMed...
    25. Cizmecioglu FM, Etiler N, Ergen A, Gormus U, Keser A, Hekim N, Hamzaoglu O, Hatun S. Association of adiponectin, resistin and high sensitive CRP level with the metabolic syndrome in childhood and adolescence. Exp Clin Endocrinol Diabetes. 2009 Nov; 117(10): 622-627. Epub 2009 Feb 20. PubMed PMID: 19235133. Go to original source... Go to PubMed...
    26. Kawada T, Hasegawa M. Predictive ability of serum high-molecular-weight adiponectin in combination with serum insulin and serum C-reactive protein for the presence of metabolic syndrome. Ann Hum Biol. 2012 Mar; 39(2): 108-112. PubMed PMID: 22324836. Go to original source... Go to PubMed...
    27. Saisho Y, Hirose H, Seino Y, Saito I, Itoh H. Usefulness of C-reactive protein to high-molecular-weight adiponectin ratio to predict insulin resistance and metabolic syndrome in Japanese men. J Atheroscler Thromb. 2010 Sep30; 17(9): 944-952. Epub 2010 Jun 11. PubMed PMID: 20543521. Go to original source... Go to PubMed...
    28. Kajikawa Y, Ikeda M, Takemoto S, Tomoda J, Ohmaru N, Kusachi S. Association of circulating levels of leptin and adiponectin with metabolic syndrome and coronary heart disease in patients with various coronary risk factors. Int Heart J. 2011; 52(1): 17-22. PubMed PMID: 21321463. Go to original source... Go to PubMed...
    29. Ara?a Rosaínz Mde J, Ojeda MO, Acosta JR, Elías-Calles LC, González NO, Herrera OT, García Álvarez CT, Rodríguez EM, Báez ME, Seijas EÁ, Valdés RF.Imbalanced low-grade inflammation and endothelial activation in patients with type 2 diabetes mellitus and erectile dysfunction. J Sex Med. 2011. Jul; 8(7): 2017-2030. doi: 10.1111/j.1743-6109.2011.02277.x. Epub 2011 May 6. PubMed PMID: 21554550. Go to original source... Go to PubMed...
    30. Li WC, Hsiao KY, Chen IC, Chang YC, Wang SH, Wu KH. Serum leptin is associated with cardiometabolic risk and predicts metabolic syndrome in Taiwanese adults. Cardiovasc Diabetol. 2011 Apr 28; 10: 36. PubMed PMID: 21526991; PubMed Central PMCID: PMC3098150. Go to original source... Go to PubMed...
    31. Hou XH, Zhu YX, Lu HJ, Chen HF, Li Q, Jiang S, Xiang KS, Jia WP. Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese. J Gastroenterol Hepatol. 2011 Apr; 26(4): 722-730. doi: 10.1111/j.1440-1746.2010.06509.x. PubMed PMID: 21418302. Go to original source... Go to PubMed...
    32. Akçay AB, Camsar? A, Ozcan T, Ciçek D, Akkuş N, Seyis S, Cimen B, Celebi B, Döven O, Cin G. The relationship between paraoxonase-1 activity and coronary artery disease in patients with metabolic syndrome. Turk Kardiyol Dern Ars. 2011 Jul; 39(5): 371-377. PubMed PMID: 21743260. Go to original source... Go to PubMed...
    33. Dong B, Ji W, Zhang Y. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Intern Med. 2011; 50(10): 1093-1097. Epub 2011 May 1. PubMed PMID: 21576834. Go to original source... Go to PubMed...
    34. Stejskal D, Karpisek M, Hanulova Z, Svestak M. Chemerin is an independent marker of the metabolic syndrome in a Caucasian population-a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008 Dec; 152(2): 217-221. PubMed PMID: 19219210. Go to original source... Go to PubMed...
    35. Brodov Y, Chouraqui P, Goldenberg I, Boyko V, Mandelzweig L, Behar S. Serum uric acid for risk stratification of patients with coronary artery disease. Cardiology. 2009; 114(4): 300-305. Epub 2009 Sep 23. PubMed PMID: 19776568. Go to original source... Go to PubMed...
    36. Ebrahimpour P, Fakhrzadeh H, Heshmat R, Bandarian F, Larijani B. Serum uric acid levels and risk of metabolic syndrome in healthy adults. Endocr Pract. 2008 Apr; 14(3): 298-304. PubMed PMID: 18463036. Go to original source... Go to PubMed...
    37. Seki S, Tsutsui K, Fujii T, Yamazaki K, Anzawa R, Yoshimura M. Association of uric acid with risk factors for chronic kidney disease and metabolic syndrome in patients with essential hypertension. Clin Exp Hypertens. 2010; 32(5): 270-277. PubMed PMID: 20662727. Go to original source... Go to PubMed...
    38. Cakal E, Ozkaya M, Engin-Ustun Y, Ustun Y. Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome. J Endocrinol Invest. 2011 Feb; 34(2): 97-100. Epub 2010 May 28. PubMed PMID: 20511727. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.